Koers Bioadaptives Inc OTC Bulletin Board
Aandelen
US09072U1079
Voedselverwerking
Omzet 2022 | 0,02 0,02 | Omzet 2023 | 0,03 0,03 | Marktkapitalisatie | 448K 420K |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | - 0 | Nettowinst (verlies) 2023 | - 0 | EV/omzet 2022 | 30.165.231 x |
Nettoschuld 2022 | 367K 344K | Nettoschuld 2023 | 268K 252K | EV/omzet 2023 | 25.075.337 x |
K/w-verhouding 2022 |
-0,07
x | K/w-verhouding 2023 |
-0,39
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 99,77% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Edward E. Jacobs
CEO | Chief Executive Officer | 83 | 15-03-18 |
Robert W. Ellis
DFI | Director of Finance/CFO | 82 | 11-09-19 |
Charles Townsend
COO | Chief Operating Officer | 78 | 31-05-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Edward E. Jacobs
CEO | Chief Executive Officer | 83 | 15-03-18 |
Robert W. Ellis
DFI | Director of Finance/CFO | 82 | 11-09-19 |
Charles Townsend
COO | Chief Operating Officer | 78 | 31-05-21 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+13,21% | 8,15 mld. | |
-0,47% | 7,23 mld. | |
+12,30% | 6,65 mld. | |
-6,99% | 3,72 mld. | |
-7,95% | 3,64 mld. | |
-4,78% | 1,31 mld. | |
+12,61% | 972 mln. | |
-43,32% | 863 mln. | |
-22,54% | 799 mln. |